Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Temitayo Ajayi

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer|November 15, 2019
Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process modelSweet Ping Ng, Temitayo Ajayi, Andrew J Schaefer, et al.
The New England Journal of Medicine|March 17, 2021
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal HemoglobinuriaPeter Hillmen, Jeff Szer, Ilene Weitz, et al.
The Lancet. Haematology|September 2, 2022
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trialRégis Peffault de Latour, Jeff Szer, Ilene C Weitz, et al.
Cells|August 12, 2022
Discovery of Novel HSP27 Inhibitors as Prospective Anti-Cancer Agents Utilizing Computer-Assisted Therapeutic Discovery ApproachesHaruna Isiyaku Umar, Adeola Temitayo Ajayi, Nobendu Mukerjee, et al.
The Lancet. Respiratory Medicine|May 20, 2014
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trialEitan Kerem, Michael W Konstan, Kris De Boeck, et al.
Cancer|February 13, 2019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Joel Berends, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer|November 15, 2019
Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process modelSweet Ping Ng, Temitayo Ajayi, Andrew J Schaefer, et al.
The New England Journal of Medicine|March 17, 2021
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal HemoglobinuriaPeter Hillmen, Jeff Szer, Ilene Weitz, et al.
The Lancet. Haematology|September 2, 2022
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trialRégis Peffault de Latour, Jeff Szer, Ilene C Weitz, et al.
Cells|August 12, 2022
Discovery of Novel HSP27 Inhibitors as Prospective Anti-Cancer Agents Utilizing Computer-Assisted Therapeutic Discovery ApproachesHaruna Isiyaku Umar, Adeola Temitayo Ajayi, Nobendu Mukerjee, et al.
The Lancet. Respiratory Medicine|May 20, 2014
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trialEitan Kerem, Michael W Konstan, Kris De Boeck, et al.
Cancer|February 13, 2019
Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapySweet Ping Ng, Courtney Pollard, Joel Berends, et al.
Pageof 3